Home

MAX REINHARDT

CIK 1780058 · President, Global Spine · last filed 2026-03-06

MAX REINHARDT is a President, Global Spine who has filed 20 SEC Form 4 insider transactions across 2 companies since 2019. The most recent filing shows the insider sold $27.2K of OFIX on Mar 6, 2026. Across all open-market trades the lifetime net is −$6.7M, making them a net seller over the disclosed history. Current disclosed insider exposure totals $1.0M across reported positions. 17 SEC filings were submitted jointly with Pacira BioSciences, Inc.

"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.

Loading insider history…
Disclosed Exposure

$1.00M

Companies

2

Total Filings

20

Lifetime Open-Market Net

-$6.65M

Filer Profile

Reported Address
3451 PLANO PARKWAY
LEWISVILLE, TX 75056
Related Filers
Pacira BioSciences, Inc. — 17 joint filings, latest 2023-06-12
Profile details as reported on the filer's SEC submissions — for individual insiders the address is often in care of the issuer. Related filers are identified from jointly filed SEC submissions and shared reported addresses. View filings on SEC EDGAR.

Holdings By Company

Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
Symbol Role Shares Price Disclosed Exposure Lifetime OM Net Filings Latest Filed
OFIX President, Global Spine 25,348 $9.44 $239.3K -$46.3K 4 2026-03-06
PCRX President, Rest of World 30,324 $25.12 $761.7K -$6.61M 13 2023-06-07

Recent Filings

20 filings
Insider activity across all companies, newest first. Form 4 rows are post-trade confirmations (buys, sells, grants, exercises). Notice (144) rows are pre-trade notices of intent to sell restricted or control stock under Rule 144 — they may not all execute. Compare adjacent dates to see which notices became actual sales.
Filed Symbol Action Net Shares Net $ Link
2026-03-06 OFIX Sell (S) −2,133 -$27.2K EDGAR
2025-06-13 OFIX Sell (S) −1,643 -$19.1K EDGAR
2025-03-05 OFIX Grant (A) +14,723 $0 EDGAR
2024-06-12 OFIX Grant (A) +14,401 $187.5K EDGAR
2023-06-12 PCRX Notice (144) −5,085 -$183.2K EDGAR
2023-06-07 PCRX Notice (144) −1,099 -$41.6K EDGAR
2023-06-07 PCRX Sell (S) −2,153 -$82.7K EDGAR
2023-06-06 PCRX Notice (144) −1,054 -$41.1K EDGAR
2022-10-11 PCRX Sell (S) −1,380 -$80.0K EDGAR
2022-06-08 PCRX Mixed +2,700 -$323.7K EDGAR
Showing 1–10 of 20
Page 1 of 2
Form 4 codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.